Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells
Glioblastoma (GBM) is an incurable primary brain cancer characterized by increased reactive oxygen species (ROS) production. The redox-sensitive tumor suppressor gene <i>TP53</i>, wild-type (wt) for 70% of patients, regulates redox homeostasis. Glioblastoma stem cells (GSCs) increase thi...
Saved in:
Main Authors: | Fatemeh Jamali (Author), Katherine Lan (Author), Paul Daniel (Author), Kevin Petrecca (Author), Siham Sabri (Author), Bassam Abdulkarim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecularly engineering a dual-drug nanoassembly for self-sensitized photodynamic therapy via thioredoxin impairment and glutathione depletion
by: Hongyuan Zhang, et al.
Published: (2022) -
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
by: Morana Jaganjac, et al.
Published: (2020) -
Kinetic Effects of Transferrin-Conjugated Gold Nanoparticles on the Antioxidant Glutathione-Thioredoxin Pathway
by: Sonia Sebastian, et al.
Published: (2023) -
Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
by: Amy E. Arnold, et al.
Published: (2018) -
Investigating the Thioredoxin and Glutathione Systems' Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl
by: Sicong Wang, et al.
Published: (2021)